Author

E. Meese

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Assay:bulk RNA-seq· 4 Approach:experimental assay· 3 Research Focus:differential expression· 2 Research Focus:host-pathogen & immune response· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

N. Ludwig· 3 shared E. C. Schwarz· 2 shared M. Hart· 2 shared M. Hoth· 2 shared V. Helms· 2 shared A. Denger· 1 shared A. K. Yanamandra· 1 shared A. Keller· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

N. Ludwig

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Th17 cells target the metabolic miR-142-5p-SDHC/SDHD axis promoting invasiveness and progression of cervical cancers

M. Pohlers, S. Gies, T. Taenzer, R. Stroeder, L. Theobald, N. Ludwig, Y.-J. Kim, R. Bohle, E. F. Solomayer, E. Meese, M. Hart, B. Walch-Rueckheim

This study identifies a Th17 cell-driven miR-142-5p-SDHC/SDHD axis that enhances cervical cancer migration and invasion, with clinical correlations to metastasis and survival.

bioRxiv · Jun 29, 2023 · PreprintCancer Biology

High glucose enhances antigen-independent CTL killing via TRAIL

W. Yang, A. Denger, C. Diener, F. Kueppers, L. Soriano-Baguet, G. Schaefer, A. K. Yanamandra, R. Zhao, A. Knoerck, E. C. Schwarz, M. Hart, F. Lammert, L. P. Roma, D. Brenner, G. Grigorios Christidis, , B. Qu

This study shows high glucose increases TRAIL expression in CTLs, promoting beta cell apoptosis, and identifies metformin and vitamin D as synergistic therapies to mitigate this effect.

bioRxiv · Aug 4, 2021Immunology

Suppression of endothelial miR-22-3p mediates non-small cell lung cancer cell-induced angiogenesis

Y. Gu, G. Pais, V. Becker, C. Körbel, E. Ampofo, E. Ebert, J. Hohneck, N. Ludwig, E. Meese, R. M. Bohle, Y. Zhao, M. D. Menger, M. W. Laschke

The paper shows that reduced endothelial miR-22-3p in NSCLC tissues promotes angiogenesis by inhibiting SIRT1 and FGFR1, leading to AKT/mTOR inactivation and tumor growth.

bioRxiv · Apr 4, 2021Cancer Biology

Identification of molecular candidates which regulate calcium-dependent CD8+ T-cell cytotoxicity

S. Zöphel, G. Schwär, M. Nazarieh, V. Konetzki, C. Hoxha, E. Meese, M. Hoth, V. Helms, M. Hamed, E. C. Schwarz

The paper identifies four molecular candidates that regulate Ca2+-dependent CD8+ T-cell cytotoxicity through transcriptome analysis and functional assays.

bioRxiv · Dec 22, 2020Immunology

Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis

A. Keller, T. Fehlmann, C. Backes, F. Kern, R. Gislefoss, H. Langseth, T. B. Rounge, N. Ludwig, E. Meese

The paper identifies circulating miRNA profiles associated with cancer decades before diagnosis using competitive learning and serum samples from a large population cohort.

bioRxiv · Mar 26, 2020Cancer Biology